BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28830266)

  • 41. [Biomarkers for the diagnosis and management of heart failure: natriuretic peptides].
    Castiglione V; Vergaro G; Aimo A; Prontera C; Musetti V; Masotti S; Battaglia D; Di Cecco P; Emdin M; Passino C
    G Ital Cardiol (Rome); 2021 Apr; 22(4):292-300. PubMed ID: 33783449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NT-proBNP and BNP: biomarkers for heart failure management.
    Bettencourt P
    Eur J Heart Fail; 2004 Mar; 6(3):359-63. PubMed ID: 14987589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multimarker testing with ST2 in chronic heart failure.
    Bayes-Genis A; Richards AM; Maisel AS; Mueller C; Ky B
    Am J Cardiol; 2015 Apr; 115(7 Suppl):76B-80B. PubMed ID: 25697916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].
    Aspromonte N; Gulizia MM; Clerico A; Di Tano G; Emdin M; Feola M; Iacoviello M; Latini R; Mortara A; Valle R; Misuraca G; Passino C; Masson S; Aimo A; Ciaccio M; Migliardi M
    G Ital Cardiol (Rome); 2016 Sep; 17(9):615-656. PubMed ID: 27869886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variability of biomarkers in patients with chronic heart failure and healthy controls.
    Meijers WC; van der Velde AR; Muller Kobold AC; Dijck-Brouwer J; Wu AH; Jaffe A; de Boer RA
    Eur J Heart Fail; 2017 Mar; 19(3):357-365. PubMed ID: 27766733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biomarkers in heart failure: the past, current and future.
    Sarhene M; Wang Y; Wei J; Huang Y; Li M; Li L; Acheampong E; Zhengcan Z; Xiaoyan Q; Yunsheng X; Jingyuan M; Xiumei G; Guanwei F
    Heart Fail Rev; 2019 Nov; 24(6):867-903. PubMed ID: 31183637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
    Leto L; Testa M; Feola M
    Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BNP in the diagnosis and risk stratification of heart failure.
    Moe GW
    Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction.
    Wessler BS; Kramer DG; Kelly JL; Trikalinos TA; Kent DM; Konstam MA; Udelson JE
    Circ Heart Fail; 2011 Sep; 4(5):578-88. PubMed ID: 21705485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-terminal pro-brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinic.
    Hamagawa K; Kubo T; Nishimura K; Baba Y; Hirota T; Yamasaki N; Kitaoka H
    Geriatr Gerontol Int; 2017 Oct; 17(10):1648-1653. PubMed ID: 27860152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evolving Role of Natriuretic Peptides from Diagnostic Tool to Therapeutic Modality.
    Pagel-Langenickel I
    Adv Exp Med Biol; 2018; 1067():109-131. PubMed ID: 29411335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
    Bhardwaj A; Rehman SU; Mohammed AA; Gaggin HK; Barajas L; Barajas J; Moore SA; Sullivan D; Januzzi JL
    Am Heart J; 2012 Nov; 164(5):793-799.e1. PubMed ID: 23137512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.
    Bhardwaj A; Januzzi JL
    Crit Pathw Cardiol; 2009 Dec; 8(4):146-50. PubMed ID: 19952548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].
    Wu YR; Chen SB; Sun K; Huang MR; Zhang YQ; Chen S
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):728-32. PubMed ID: 17229370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association.
    Chow SL; Maisel AS; Anand I; Bozkurt B; de Boer RA; Felker GM; Fonarow GC; Greenberg B; Januzzi JL; Kiernan MS; Liu PP; Wang TJ; Yancy CW; Zile MR;
    Circulation; 2017 May; 135(22):e1054-e1091. PubMed ID: 28446515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: is BNP or NT-proBNP a useful assessment tool?
    Balion CM; McKelvie RS; Reichert S; Santaguida P; Booker L; Worster A; Raina P; McQueen MJ; Hill S
    Clin Biochem; 2008 Mar; 41(4-5):266-76. PubMed ID: 17991434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
    Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
    Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Applications of Biomarkers in Atrial Fibrillation.
    Chang KW; Hsu JC; Toomu A; Fox S; Maisel AS
    Am J Med; 2017 Dec; 130(12):1351-1357. PubMed ID: 28822701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.